Atlas FDA

Platinium VR 1210, Platinium VR 1240, ENERGYA VR 3110, TALENTIA VR 3210, ENERGYA VR 3140, TALENTIA VR 3240, Platinium DR

FDA premarket approval P980049/S147 · decided 2025-07-23

Approval details

PMA number
P980049
Supplement
S147
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Platinium VR 1210, Platinium VR 1240, ENERGYA VR 3110, TALENTIA VR 3210, ENERGYA VR 3140, TALENTIA VR 3240, Platinium DR
Generic name
DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER
Applicant
MicroPort CRM USA, Inc.
Date received
2025-04-18
Decision date
2025-07-23
Days to decision
96 days
Decision code
APPR
Product code
MRM
Advisory committee
Cardiovascular
Expedited review
No
Location
Arlington, TN
Statement
Approval for the addition of Mylar spacers to our ALIZEA/CELEA pacemakers, allow hybrid tab replacements to occur at Microport’s Saluggia, Italy facility, and changes in manufacturing processes of other MicroPort’s pacemaker, ICD, and CRT-D systems.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.